Ad blocking detected

Thank you for visiting CanadianInsider.com. We have detected you cannot see ads being served on our site due to blocking. Unfortunately, due to the high cost of data, we cannot serve the requested page without the accompanied ads.

If you have installed ad-blocking software, please disable it (sometimes a complete uninstall is necessary). Private browsing Firefox users should be able to disable tracking protection while visiting our website. Visit Mozilla support for more information. If you do not believe you have any ad-blocking software on your browser, you may want to try another browser, computer or internet service provider. Alternatively, you may consider the following if you want an ad-free experience.

Canadian Insider Ultra Club
$500/ year*
Daily Morning INK newsletter
+3 months archive
Canadian Market INK weekly newsletter
+3 months archive
30 publication downloads per month from the PDF store
Top 20 Gold, Top 30 Energy, Top 40 Stock downloads from the PDF store
All benefits of basic registration
No 3rd party display ads
JOIN THE CLUB

* Price is subject to applicable taxes.

Paid subscriptions and memberships are auto-renewing unless cancelled (easily done via the Account Settings Membership Status page after logging in). Once cancelled, a subscription or membership will terminate at the end of the current term.

Relay Medical Corp. (C:RELA)

Business Focus: Medical Diagnostic & Testing Equipment

INK Edge Outlook

Insider Chart - Past 6 Months

INK Ultra Money Free

Insider Filings

Latest 10 SEDI filings for RELA within the last 6 months
Loading...
See all filings within the past 6 months

Company News

Dec 07, 2021 08:00 ET
Relay Changes Its Name to Scryb Inc.
Toronto, Ontario--(Newsfile Corp. - December 7, 2021) - Relay Medical Corp. (CSE: RELA) (OTCQB: RYMDF) (FSE: EIY2) ("Relay" or the "Company") announces that it has filed articles of amendment, with an effective date of December 8, 2021, to change its name to "Scryb Inc." The Company's new stock symbol on the Canadian Securities Exchange will be "SCYB," and the Company expects its shares will commence trading under the new name and ticker symbol on or about market opening on or about Thursday, December 9, 2021.
Read full article
Dec 03, 2021 16:58 ET
Relay to Rebrand as Scryb Inc. with Launch of Unified Platform
Toronto, Ontario--(Newsfile Corp. - December 3, 2021) - Relay Medical Corp. (CSE: RELA) (OTCQB: RYMDF) (FSE: EIY2) ("Relay" or the "Company") is pleased to announce that further to the release issued September 9, 2021, and special meeting on September 20, 2021 the Company is now set for the launch of the new name and brand 'Scryb Inc.' The pronunciation of Scryb is /skraɪb/, ("scribe"), and is a combination of "scry", meaning to predict, and "scribe" meaning to diligently document, two key components of the Company's methodologies and platform technology. In addition, the Company's Canadian Securities Exchange ("CSE") stock symbol will change to "SCYB".
Read full article
See more news stories

Valuation Ratios

Industry
Sector
Beta
0.51
--
--
Price to Sales - TTM
116.10
--
10.24
Price to Book - most recent quarter
2.29
2.04
2.62
Price to Cash Flow per share - TTM
--
--
12.49
Price to Free Cash Flow per share - TTM
--
--
30.15
See all valuations

Short Report

DateNumber of Shares ShortedNet Change
Nov 30, 2021538,132498,477
Nov 15, 202139,655-170,579
Oct 31, 2021210,234195,435
See Short Report

Business Summary

Sector:  Healthcare Industry:  Advanced Medical Equipment & Technology

Relay Medical Corp. is a Canada-based medical technology company. The Company is focused on the development of technologies in the diagnostics, artificial intelligence (AI) data science and cybersecurity sectors. Its portfolio includes Cybeats, Fionet, HemoPalm, Pharmatrac and other. Cybeats is an integrated security platform designed to secure and protect high-valued connected devices. Its Fionet Platform is an end-to-end, rapid testing and tracking solution for community-based or decentralized settings. Its HemoPalm is developing a series of point-of-care testing (POCT) unit-use cartridge-based blood analyzers with full enterprise capabilities, which brings lab-quality analysis to the bedside in critical care situations, such as the intensive care unit (ICU), neonatal intensive care unit (NICU) and emergency room (ER). Its Pharmatrac System predicts medication behavior and delivers actionable recommendations for the care team to improve medication adherence of patients.

See business summary

 

Twitter

Search (past week) for $RELA.CA